EX-99.1 2 dex991.htm MONTHLY OPERATING REPORT Monthly Operating Report

SCHEDULE OF RECEIPTS AND DISBURSEMENTS

 

FOR THE PERIOD BEGINNING: June 1, 2009    Period ending June 30, 2009
Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Date of Petition: November 10, 2008   

 

     CURRENT
MONTH
   CUMULATIVE
PETITION

TO DATE

1. FUNDS AT BEGINNING OF PERIOD

   $ 4,735.81    $ 281,590.31

2. RECEIPTS:

     

A. Cash Sales

     

B. Accounts Receivable

     

C. Other Receipts (See MOR-3)

     10,445.32      366,427.47

D. Transfer from subsidiaries – TEAMM

     —        215,644.58

                                      – Analytica

     206,000.00      1,148,088.38

                                      – A.S.P.

     —        30,731.41

                                      – AccentRx

     —        4,327.23

                                       – Biovest (shared expenses)

     20,600.00      340,166.60

3. TOTAL RECEIPTS (Lines 2A+2B+2C)

     237,045.32      2,105,385.67

4. TOTAL FUNDS AVAILABLE FOR OPERATIONS (1+3)

     241,781.13      2,386,975.98

5. DISBURSEMENTS

     

A. Advertising

     —        —  

B. Bank Charges / Payroll Fees

     1,263.98      12,090.41

C. Contract Labor

     —        —  

D. Fixed Asset Payments (not incl in N)

     —        —  

E. Insurance

     47,130.50      572,493.02

F. Inventory Payments (See Attach. 2)

     —        —  

G. Leases

     1,512.64      6,664.99

H. Manufacturing Supplies

     —        —  

I. Office Supplies

     4,428.89      18,341.02

J. Payroll – Net (see Attachment 4B)

     65,950.97      719,467.99

K. Professional Fees (Accounting/Legal)

     35,925.00      146,067.96

L. Rent

     15,433.50      120,125.08

M. Repairs and Maintenance

     —        360.00

N. Secured Creditor Payments (Attach. 2)

     —        —  

O. Taxes Paid – Payroll (Attach. 4C)

     25,591.21      321,489.74

P. Taxes Paid – Sales and Use (Attach. 4C)

     —        —  

Q. Taxes Paid – Other (Attach. 4C)

     —        1,000.00

R. Telephone / Internet

     11,723.36      63,780.08

S. Travel and Entertainment

     —        18,690.62

Y. U.S. Trustee Quarterly Fees

     —        22,750.00

U. Utilities

     —        819.31

V. Vehicle Expenses

     —        —  

W. Other Operating Expenses (See MOR-3)

     —        34,929.71

X. Transfer to subsidiaries – Analytica

     —        270,084.97

                                  – Biovest (shared expenses)

     —        25,000.00

TOTAL DISBURSEMENTS (Sum of 5A thru W)

     208,960.05      2,354,154.90

ENDING BALANCE (Line 4 Minus Line 6)(c)

     32,821.08      32,821.08

I declare under penalty of perjury that this statement and the accompanying documents and reports are true and correct to the best of my knowledge and belief.

 

This 20th day of July, 2009

   

/s/ Alan M. Pearce

   

(Signature)

 

(a) This number is carried forward from last month’s report. For the first report only, this number will be the balance as of the petition date.
(b) This figure will not change from month to month. It is always the amount of funds on hand as of the date of the petition.
(c) These two amounts will always be the same if form is completed correctly.

 

MOR-1


MONTHLY SCHEDULE OF RECEIPTS AND DISBURSEMENTS (cont’d)

Detail of Other Receipts and Other Disbursements

OTHER RECEIPTS:

Describe Each Item of Other Receipt and List Amount of Receipt. Write totals on Page MOR-2, Line 2C.

 

Description

   Current
Month
   Cumulative
Petition
to Date

Collections for TEAMM receivables and Cobra

   $ —      $ 254,474.27

Rent reimbursement from BDSI

     —        12,530.08

Workers compensation refund

     —        4,788.48

Collections for A.S.P. receivables

     3,548.78      37,976.80

COBRA checks for Accentia

     6,896.54      56,657.84

TOTAL OTHER RECEIPTS

   $ 10,445.32    $ 366,427.47
             

“Other Receipts” includes Loans from Insiders and other sources (i.e. Officer/Owner, related parties directors, related corporations, etc.). Please describe below: N/A

 

Loan Amount

  

Source of Funds

  

Purpose

   Repayment Schedule

N/A

        

OTHER DISBURSEMENTS:

Describe Each Item of Other Disbursement and List Amount of Disbursement. Write totals on Page MOR-2, Line 5W.

 

Description

   Current
Month
   Cumulative
Petition
to Date

Southeastern Document Service – document handling for bankruptcy filing

   $ 0    $ 1,247.60

RR Donnelly – SEC filings

   $ 0    $ 4,700.00

Garrison Hasara – overnight postage charge for payroll disbursement (Fed-Ex refused service)

   $ 0    $ 1,087.24

Florida Department of State

   $ 0    $ 600.00

Settlement with DDN

   $ 0    $ 7,500.00

Bill McNulty – moving expenses (closed 2nd floor of Tampa office)

   $ 0    $ 986.57

Promontech – sample inventory destruction

   $ 0    $ 18,808.30

TOTAL OTHER DISBURSEMENTS

   $ 0    $ 34,929.71

NOTE: Attach a current Balance Sheet and Income (Profit & Loss) Statement.

 

MOR-2


ATTACHMENT 1

MONTHLY ACCOUNTS RECEIVABLE RECONCILIATION AND AGING

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning June 1, 2009    Period ending June 30, 2009

 

ACCOUNTS RECEIVABLE AT PETITION DATE:

          N/A                                                             

ACCOUNTS RECEIVABLE RECONCILIATION

(Include all accounts receivable, pre-petition and post-petition, including charge card sales which have not been received):

 

Beginning of Month Balance(a)

   $             

PLUS: Current Month New Billings

  

MINUS: Collection During the Month(b)

   $             

PLUS/MINUS: Adjustments or Write-offs*

   $             

End of Month Balance(c)

   $             

 

* For any adjustments or Write-offs provide explanation and supporting documentation, if applicable:

 

 

 

POST PETITION ACCOUNTS RECEIVABLE AGING

(Show the total for each aging category for all accounts receivable)

 

0-30 Days

  

31-60 Days

  

61-90 Days

  

Over 90Days

  

Total(c)

$            

   $                $                $                $            

For any receivables in the “Over 90 Days” category, please provide the following: N/A

 

Receivable Customer

  

Date

  

Status (Collection efforts taken,

estimate of collectability, write-off,

disputed account, etc.)

N/A

     
     
     
     

 

(a) This number is carried forward from last month’s report. For the first report only, this number will be the balance as of the petition date.
(b) This must equal the number reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 2B).
(c) These two amounts must equal.

 

MOR-3


ATTACHMENT 2

MONTHLY ACCOUNTS PAYABLE AND SECURED PAYMENTS REPORT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning June 1, 2009    Period ending June 30, 2009

In the space below list all invoices or bills incurred and not paid since the filing of the petition. Do not include amounts owed prior to filing the petition. In the alternative, a computer generated list of payables may be attached provided all information requested below is included. SEE ATTACHED

POST-PETITION ACCOUNTS PAYABLE

 

Date Incurred

  

Date

Outstanding

  

Vendor

  

Description

  

Amount

See attached

           
           
           
           
        

TOTAL AMOUNT(b)

  

 

¨   Check here if pre-petition debts have been paid. Attach an explanation and copies of supporting documentation.

 

 

ACCOUNTS PAYABLE RECONCILIATION (Post Petition Unsecured Debt Only)

 

Opening Balance(a)

   $ 127,838.83   

PLUS: New Indebtedness Incurred This Month

     107,917.82   

MINUS: Amount Paid on Post Petition, Accounts Payable This Month

     (117,417.87

PLUS/MINUS: Adjustments*

     *   

Ending Month Balance(c)

   $ 118,338.78   

 

* For any adjustments provide explanation and supporting documentation, if applicable.

 

 

SECURED PAYMENTS REPORT

List the status of Payments to Secured Creditors and Lessors (Post Petition Only). If you have entered into a modification agreement with a secured creditor/lessor, consult with your attorney and the United States Trustee Program prior to completing this section).

 

Secured Creditor/Lessor

   Date
Payment
Due This
Month
   Amount
Paid This
Month
   Number of
Post Petition
Payments
Delinquent
   Total Amount of
Post Petition
Payments
Delinquent

N/A

           
           
           

Total(d)

           

 

(a) This number is carried forward from last month’s report. For the first report only, this number will be zero.
(b,c) The total of line (b) must equal line (c).
(d) This number is reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line5N).

 

MOR-4


ATTACHMENT 3

INVENTORY AND FIXED ASSETS REPORT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning June 1, 2009    Period ending June 30, 2009

INVENTORY REPORT

 

INVENTORY BALANCE AT PETITION DATE:

   $      N/A

INVENTORY RECONCILIATION:

     

Inventory Balance at Beginning of Month(a)

   $     

PLUS: Inventory Purchased During Month

   $     

MINUS: Inventory Used or Sold

   $     

PLUS/MINUS: Adjustments or Write-downs*

   $     

Inventory on Hand at End of Month

   $     

METHOD OF COSTING INVENTORY:                                                                                                        

 

* For any adjustments or write-downs provide explanation and supporting documentation, if applicable.

 

 

INVENTORY AGING

 

Less than 6

months old

  

6 months to 2

years old

  

Greater than 2
years old

  

Considered
Obsolete

       

Total

%

   %    %    %    =    100%*

 

* Aging Percentages must equal 100%.
¨ Check here if inventory contains perishable items.

Description of Obsolete Inventory:                                                                                                        

FIXED ASSET REPORT

FIXED ASSETS FAIR MARKET VALUE AT PETITION DATE(b):    $95,604.47

(Includes Property, Plant and Equipment)

BRIEF DESCRIPTION (First Report Only):                                                                                                        

FIXED ASSETS RECONCILIATION:

 

Fixed Asset Book Value at Beginning of Month(a) (b)

   $ 62,623.77

MINUS: Depreciation Expense

   $ 3,436.27

PLUS: New Purchases

     —  

PLUS/MINUS: Adjustments or Write-downs*

     —  

Ending Monthly Balance

   $ 59,187.50

 

* For any adjustments or write-downs, provide explanation and supporting documentation, if applicable.

BRIEF DESCRIPTION OF FIXED ASSETS PURCHASED OR DISPOSED OF DURING THE REPORTING PERIOD:              N/A                                                                          

 

(a) This number is carried forward from last month’s report. For the first report only, this number will be the balance as of the petition date.
(b) Fair Market Value is the amount at which fixed assets could be sold under current economic conditions. Book Value is the cost of the fixed assets minus accumulated depreciation and other adjustments.

 

MOR-5


ATTACHMENT 4A

MONTHLY SUMMARY OF BANK ACTIVITY - OPERATING ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning June 1, 2009    Period ending June 30, 2009

Attach a copy of current month bank statement and bank reconciliation to this Summary of Bank Activity. A standard bank reconciliation form can be found at http://www.usdoj.gov/ust/r21/index.htm. If bank accounts other than the three required by the United States Trustee Program are necessary, permission must be obtained from the United States Trustee prior to opening the accounts. Additionally, use of less than the three required bank accounts must be approved by the United States Trustee.

 

NAME OF BANK: Wachovia Bank, NA   BRANCH:                                                                                  
ACCOUNT NAME: Accentia Master Account DIP  

ACCOUNT NUMBER: *********1478

PURPOSE OF ACCOUNT:              MASTER ACCOUNT                                                     

 

Ending Balance per Bank Statement

   $ 0

Plus Total Amount of Outstanding Deposits

   $ 0

Minus Total Amount of Outstanding Checks and other debits*

   $ 0

Minus Service Charges

   $ 0

Ending Balance per Check Register**(a)

   $ 0

 

* Debit cards are used by               N/A                                                             
** If Closing Balance is negative, provide explanation:               N/A                                                             

The following disbursements were paid in Cash (do not include items reported as Petty Cash on Attachment 4D: (¨ Check here if cash disbursements were authorized by United States Trustee)

 

Date

   Amount   

Payee

  

Purpose

  

Reason for Cash Disbursement

           
           
           
           
           
           

TRANSFERS BETWEEN DEBTOR IN POSSESSION ACCOUNTS

“Total Amount of Outstanding Checks and other debits”, listed above, includes:

$                               Transferred to Payroll Account

$                               Transferred to Tax Account

 

(a) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule of Receipts and Disbursements (Page MOR-2, Line 7).

 

MOR-6


ATTACHMENT 5A

CHECK REGISTER - OPERATING ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning June 1, 2009    Period ending June 30, 2009

 

NAME OF BANK: Wachovia Bank, NA   BRANCH:             Tampa                                                                     
ACCOUNT NAME: Accentia Operating   ACCOUNT NUMBER: *********1478
PURPOSE OF ACCOUNT:                     MASTER ACCOUNT                                                     

Account for all disbursements, including voids, lost checks, stop payments, etc. In the alternative, a computer generated check register can be attached to this report, provided all the information requested below is included. NONE

 

DATE

   CHECK
NUMBER
  

PAYEE

  

PURPOSE

   AMOUNT
           
     

Account closed to reduce fees

     
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
         TOTAL    $  

 

MOR-7


ATTACHMENT 4A2

MONTHLY SUMMARY OF BANK ACTIVITY - OPERATING ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning June 1, 2009    Period ending June 30, 2009

Attach a copy of current month bank statement and bank reconciliation to this Summary of Bank Activity. A standard bank reconciliation form can be found at http://www.usdoj.gov/ust/r21/index.htm. If bank accounts other than the three required by the United States Trustee Program are necessary, permission must be obtained from the United States Trustee prior to opening the accounts. Additionally, use of less than the three required bank accounts must be approved by the United States Trustee.

 

NAME OF BANK: Wachovia Bank, NA   BRANCH:                                                                          
ACCOUNT NAME: Accentia Operating Account DIP  

ACCOUNT NUMBER: *********1494

PURPOSE OF ACCOUNT:                     OPERATING                                                     

 

Ending Balance per Bank Statement

   $ 0

Plus Total Amount of Outstanding Deposits

   $ 0

Minus Total Amount of Outstanding Checks and other debits*

   $ 32,821.08

Minus Service Charges

   $ 0

Ending Balance per Check Register**(a)

   $ 32,821.08

 

* Debit cards are used by  N/A                                         
** If Closing Balance is negative, provide explanation:        ZBA bank account balance always zero                                        

The following disbursements were paid in Cash (do not include items reported as Petty Cash on Attachment 4D: (¨ Check here if cash disbursements were authorized by United States Trustee)

 

Date

   Amount   

Payee

  

Purpose

  

Reason for Cash Disbursement

           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           

 

MOR-8


ATTACHMENT 5A2

CHECK REGISTER - OPERATING ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning June 1, 2009    Period ending June 30, 2009

 

NAME OF BANK: Wachovia Bank, NA   BRANCH:             Tampa                                                                     
ACCOUNT NAME: Accentia Operating   ACCOUNT NUMBER: *********1494
PURPOSE OF ACCOUNT:                     OPERATING                                                     

Account for all disbursements, including voids, lost checks, stop payments, etc. In the alternative, a computer generated check register can be attached to this report, provided all the information requested below is included. SEE SEPARATE REGISTER

 

DATE

  

CHECK
NUMBER

  

PAYEE

  

PURPOSE

   AMOUNT
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
        

TOTAL

   $  

 

MOR-9


ATTACHMENT 4B

MONTHLY SUMMARY OF BANK ACTIVITY - PAYROLL ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning June 1, 2009    Period ending June 30, 2009

Attach a copy of current month bank statement and bank reconciliation to this Summary of Bank Activity. A standard bank reconciliation form can be found at http://www.usdoj.gov/ust/r21/index.htm.

 

NAME OF BANK:         N/A                   BRANCH:             N/A                                                                     
ACCOUNT NAME:                                            ACCOUNT NUMBER:                                     
PURPOSE OF ACCOUNT:             PAYROLL                                                     

 

Ending Balance per Bank Statement

   $

Plus Total Amount of Outstanding Deposits

   $

Minus Total Amount of Outstanding Checks and other debits*

   $

Minus Service Charges

   $

Ending Balance per Check Register**(a)

   $

 

* Debit cards must not be issued on this account.
** If Closing Balance is negative, provide explanation:                                                              

The following disbursements were paid by Cash: (¨ Check here if cash disbursements were authorized by United States Trustee)

 

Date

   Amount   

Payee

  

Purpose

  

Reason for Cash Disbursement

           
           
           
           
           
The following non-payroll disbursements were made from this account:

Date

   Amount   

Payee

  

Purpose

  

Reason for Disbursement from account

           
           
           
           
           

 

(a) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule of Receipts and Disbursements (Page MOR-2, Line 7).

 

MOR-10


ATTACHMENT 5B

CHECK REGISTER - PAYROLL ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning June 1, 2009    Period ending June 30, 2009

 

NAME OF BANK:         N/A                   BRANCH:             N/A                                                                     
ACCOUNT NAME:                                            ACCOUNT NUMBER:                                     
PURPOSE OF ACCOUNT:             PAYROLL                                                     

Account for all disbursements, including voids, lost payments, stop payment, etc. In the alternative, a computer generated check register can be attached to this report, provided all the information requested below is included.

 

DATE

  

CHECK
NUMBER

  

PAYEE

  

PURPOSE

   AMOUNT
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
        

TOTAL

   $  

 

MOR-11


ATTACHMENT 4C

MONTHLY SUMMARY OF BANK ACTIVITY - TAX ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning June 1, 2009    Period ending June 30, 2009

Attach a copy of current month bank statement and bank reconciliation to this Summary of Bank Activity. A standard bank reconciliation form can be found on the United States Trustee website, http://www.usdoj.gov/ust/r21/index.htm.

 

NAME OF BANK:         N/A                   BRANCH:             N/A                                                                     
ACCOUNT NAME:                                            ACCOUNT NUMBER:                                     
PURPOSE OF ACCOUNT:             TAX                                                     

 

Ending Balance per Bank Statement

   $

Plus Total Amount of Outstanding Deposits

   $

Minus Total Amount of Outstanding Checks and other debits*

   $

Minus Service Charges

   $

Ending Balance per Check Register**(a)

   $

 

* Debit cards must not be issued on this account.
** If Closing Balance is negative, provide explanation:             N/A                                 

The following disbursements were paid by Cash: (¨ Check here if cash disbursements were authorized by United States Trustee)

 

Date

   Amount   

Payee

  

Purpose

  

Reason for Cash Disbursement

           
           
           

The following non-tax disbursements were made from this account: N/A

 

Date

   Amount   

Payee

  

Purpose

  

Reason for Disbursement from account

           
           
           
           
           

 

(a) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule of Receipts and Disbursements (Page MOR-2, Line 7).

 

MOR-12


ATTACHMENT 5C

CHECK REGISTER - TAX ACCOUNT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning June 1, 2009    Period ending June 30, 2009

 

NAME OF BANK:         N/A                   BRANCH:             N/A                                                                     
ACCOUNT NAME:                                            ACCOUNT NUMBER:                                     
PURPOSE OF ACCOUNT:             TAX                                                     

Account for all disbursements, including voids, lost checks, stop payments, etc. In the alternative, a computer-generated check register can be attached to this report, provided all the information requested below is included.

 

DATE

  

CHECK
NUMBER

  

PAYEE

  

PURPOSE

   AMOUNT
           
           
           
           
           
           
           
           
           
           
        

TOTAL(d)

   $

 

* This amount was paid by check through the Accentia Operating Account.

SUMMARY OF TAXES PAID

 

Payroll Taxes Paid(a)

   $ 25,591.21

Sales & Use Taxes Paid(b)

   $ 0

Other Taxes Paid(c)

   $ 0

TOTAL(d)

   $ 25,591.21

 

(a) This number is reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 5O).
(b) This number is reported in the “Current Month” column of Schedule or Receipts and Disbursements (Page MOR-2, Line 5P).
(c) This number is reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 5Q).
(d) These two lines must be equal.

 

MOR-13


ATTACHMENT 4D

INVESTMENT ACCOUNTS AND PETTY CASH REPORT

INVESTMENT ACCOUNTS

Each savings and investment account, i.e. certificates of deposits, money market accounts, stocks and bonds, etc., should be listed separately. Attach copies of account statements.

Type of Negotiable

 

Instrument

   Face
Value
   Purchase
Price
  

Date of
Purchase

   Current
Market
Value

N/A

           
           
           
           
           
           
           
        

TOTAL(a)

   $  

PETTY CASH REPORT

The following Petty Cash Drawers/Accounts are maintained:

 

Location of Box/Account

   (Column 2)
Maximum
Amount of Cash
in Drawer/Acct.
   (Column 3)
Amount of
Petty Cash
On Hand At
End of Month
  (Column 4)
Difference
between
(Column 2)
and (Column 3)

N/A

       
       
       
       
       
       
       
      TOTAL(b)   $  

For any Petty Cash Disbursements over $100 per transaction, attach copies of receipts. If there are no receipts, provide an explanation                                                                                  

TOTAL INVESTMENT ACCOUNTS AND PETTY CASH (a+ b) $                                         (c)

 

(c) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule of Receipts and Disbursements (Page MOR-2, Line 7).

 

MOR-14


ATTACHMENT 6

MONTHLY TAX REPORT

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning June 1, 2009    Period ending June 30, 2009

TAXES OWED AND DUE

Report all unpaid post-petition taxes including Federal and State withholding FICA, State sales tax, property tax, unemployment tax, State workmen’s compensation, etc.

 

Name of Taxing Authority

   Date
Payment Due
   Description    Amount    Date of
Last Tax
Return
Filed
   Tax Return
Period

N/A

              
              
              
              
              
              
              
      TOTAL    $                   

 

MOR-15


ATTACHMENT 7

SUMMARY OF OFFICER OR OWNER COMPENSATION

SUMMARY OF PERSONNEL AND INSURANCE COVERAGES

 

Name of Debtor: Accentia Biopharmaceuticals, Inc.    Case Number: 8:08-bk-17795-KRM
Reporting Period beginning June 1, 2009    Period ending June 30, 2009

Report all forms of compensation received by or paid on behalf of the Officer or Owner during the month. Include car allowances, payments to retirement plans, loan repayments, payments of Officer/Owner’s personal expenses, insurance premium payments, etc. Do not include reimbursement for business expenses Officer or Owner incurred and for which detailed receipts are maintained in the accounting records.

 

Name of Officer or Owner

  

Title

   Payment Description    Amount Paid
Samuel Duffey    President, General Counsel    Salary    $ 13,961.54
Alan Pearce    C.F.O.    Salary      11,452.18
        
        

PERSONNEL REPORT

 

     Full Time    Part Time

Number of employees at beginning of period

   12    1

Number hired during the period

   0    0

Number terminated or resigned during period

   1    0

Number of employees on payroll at end of period

   11    1

 

 

CONFIRMATION OF INSURANCE

List all policies of insurance in effect, including but not limited to workers’ compensation, liability, fire, theft, comprehensive, vehicle, health and life. For the first report, attach a copy of the declaration sheet for each type of insurance. For subsequent reports, attach a certificate of insurance for any policy in which a change occurs during the month (new carrier, increased policy limits, renewal, etc.). SEE ATTACHED

 

Agent and/or Carrier

  

Phone
Number

  

Policy
Number

  

Coverage
Type

  

Expiration
Date

  

Date
Premium
Due

              
              

The following lapse in insurance coverage occurred this month: N/A

 

Policy Type

  

Date Lapsed

  

Date
Reinstated

  

Reason for Lapse

        
        

 

¨ Check here if U. S. Trustee has been listed as Certificate Holder for all insurance policies.

 

MOR-16


ATTACHMENT 8

SIGNIFICANT DEVELOPMENTS DURING REPORTING PERIOD

Information to be provided on this page, includes, but is not limited to: (1) financial transactions that are not reported on this report, such as the sale of real estate (attach closing statement); (2) non-financial transactions, such as the substitution of assets or collateral; (3) modifications to loan agreements; (4) change in senior management, etc. Attach any relevant documents. N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

We anticipate filing a Plan of Reorganization and Disclosure Statement on or before         .

 

MOR-17